Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05360238
Title Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mustang Bio
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.